Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cytomegalovirus | 17 | 2022 | 733 | 1.860 |
Why?
|
Cytomegalovirus Infections | 16 | 2022 | 820 | 1.600 |
Why?
|
Antiviral Agents | 42 | 2022 | 2984 | 1.500 |
Why?
|
Simplexvirus | 41 | 2002 | 803 | 1.330 |
Why?
|
Acyclovir | 34 | 2004 | 272 | 1.310 |
Why?
|
Ganciclovir | 20 | 2022 | 258 | 1.240 |
Why?
|
HIV-1 | 30 | 2022 | 6939 | 1.070 |
Why?
|
Virus Replication | 23 | 2011 | 2535 | 0.750 |
Why?
|
HIV Infections | 27 | 2023 | 16715 | 0.730 |
Why?
|
Viral Vaccines | 5 | 2023 | 636 | 0.660 |
Why?
|
HIV Reverse Transcriptase | 7 | 2011 | 213 | 0.650 |
Why?
|
Drug Resistance, Microbial | 31 | 2001 | 860 | 0.650 |
Why?
|
RNA, Viral | 20 | 2009 | 2901 | 0.570 |
Why?
|
Anti-HIV Agents | 10 | 2012 | 4255 | 0.560 |
Why?
|
DNA-Directed DNA Polymerase | 17 | 2003 | 486 | 0.530 |
Why?
|
Herpesviridae Infections | 4 | 2009 | 277 | 0.530 |
Why?
|
Herpes Zoster | 6 | 2011 | 264 | 0.500 |
Why?
|
Didanosine | 8 | 1997 | 153 | 0.500 |
Why?
|
Acquired Immunodeficiency Syndrome | 20 | 2009 | 2232 | 0.480 |
Why?
|
DNA, Viral | 27 | 2009 | 2226 | 0.480 |
Why?
|
Zidovudine | 12 | 1996 | 620 | 0.480 |
Why?
|
Genes, Viral | 13 | 1993 | 718 | 0.450 |
Why?
|
Guanine | 15 | 1996 | 274 | 0.430 |
Why?
|
Herpes Simplex | 9 | 2002 | 470 | 0.430 |
Why?
|
HIV Long Terminal Repeat | 3 | 2022 | 88 | 0.420 |
Why?
|
Catholicism | 1 | 2011 | 30 | 0.400 |
Why?
|
Gene Products, gag | 2 | 2002 | 337 | 0.370 |
Why?
|
Herpes Genitalis | 6 | 2011 | 140 | 0.370 |
Why?
|
Viral Proteins | 9 | 2003 | 1899 | 0.360 |
Why?
|
Chlorobenzenes | 2 | 2000 | 28 | 0.350 |
Why?
|
Ribavirin | 8 | 1996 | 394 | 0.350 |
Why?
|
Phosphonoacetic Acid | 11 | 1992 | 55 | 0.350 |
Why?
|
Herpesvirus 2, Human | 3 | 2011 | 189 | 0.340 |
Why?
|
Muromegalovirus | 1 | 2009 | 31 | 0.340 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2007 | 365 | 0.330 |
Why?
|
HIV | 6 | 2010 | 1604 | 0.330 |
Why?
|
Capsid | 2 | 2002 | 437 | 0.330 |
Why?
|
Naphthalenes | 2 | 2000 | 194 | 0.320 |
Why?
|
Capsid Proteins | 2 | 2002 | 479 | 0.310 |
Why?
|
Hematopoietic Stem Cells | 4 | 2010 | 3389 | 0.290 |
Why?
|
Leukocytes, Mononuclear | 7 | 2011 | 1836 | 0.280 |
Why?
|
Herpesviridae | 5 | 1992 | 109 | 0.280 |
Why?
|
Valine | 3 | 2004 | 413 | 0.280 |
Why?
|
Herpesvirus 8, Human | 1 | 2008 | 258 | 0.280 |
Why?
|
Viral Envelope Proteins | 2 | 2004 | 635 | 0.270 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2012 | 1872 | 0.270 |
Why?
|
Coronavirus Infections | 1 | 2023 | 3134 | 0.260 |
Why?
|
Thymidine Kinase | 13 | 2000 | 290 | 0.260 |
Why?
|
Ribonucleosides | 5 | 1988 | 82 | 0.250 |
Why?
|
Diphtheria Toxin | 2 | 1997 | 255 | 0.240 |
Why?
|
Foscarnet | 7 | 2003 | 38 | 0.240 |
Why?
|
AIDS-Related Opportunistic Infections | 7 | 2009 | 656 | 0.230 |
Why?
|
Drug Resistance, Viral | 3 | 2022 | 820 | 0.230 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2003 | 60 | 0.220 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 2 | 2022 | 437 | 0.220 |
Why?
|
Nucleocapsid Proteins | 1 | 2002 | 77 | 0.210 |
Why?
|
Viral Structural Proteins | 3 | 1991 | 103 | 0.210 |
Why?
|
Organophosphorus Compounds | 4 | 1989 | 213 | 0.200 |
Why?
|
Myocarditis | 12 | 2005 | 768 | 0.200 |
Why?
|
Chromatin | 2 | 2023 | 2931 | 0.190 |
Why?
|
Cell Fusion | 1 | 2000 | 297 | 0.180 |
Why?
|
Endocarditis, Bacterial | 3 | 1994 | 455 | 0.170 |
Why?
|
Immunocompromised Host | 1 | 2004 | 847 | 0.170 |
Why?
|
Encephalomyocarditis virus | 6 | 2005 | 20 | 0.170 |
Why?
|
Immunoglobulin G | 2 | 2010 | 4561 | 0.170 |
Why?
|
Disease Transmission, Infectious | 1 | 2004 | 546 | 0.160 |
Why?
|
Polymerase Chain Reaction | 9 | 2009 | 6170 | 0.160 |
Why?
|
Interleukin-2 | 2 | 1997 | 1904 | 0.160 |
Why?
|
Herpesvirus 1, Human | 1 | 2003 | 743 | 0.150 |
Why?
|
Opportunistic Infections | 3 | 1991 | 389 | 0.150 |
Why?
|
RNA Splicing | 1 | 2002 | 907 | 0.150 |
Why?
|
Humans | 119 | 2023 | 743811 | 0.150 |
Why?
|
Topoisomerase I Inhibitors | 1 | 1997 | 65 | 0.150 |
Why?
|
Herpes Labialis | 5 | 1984 | 29 | 0.140 |
Why?
|
Multipotent Stem Cells | 2 | 2010 | 186 | 0.140 |
Why?
|
2-Aminopurine | 1 | 1996 | 13 | 0.140 |
Why?
|
HIV Core Protein p24 | 6 | 2011 | 256 | 0.140 |
Why?
|
Mutation | 22 | 2022 | 29777 | 0.140 |
Why?
|
DNA Helicases | 1 | 2002 | 861 | 0.140 |
Why?
|
RNA, Messenger | 5 | 2007 | 13028 | 0.140 |
Why?
|
Camptothecin | 2 | 1997 | 576 | 0.140 |
Why?
|
Acute-Phase Proteins | 1 | 1997 | 262 | 0.140 |
Why?
|
HIV Seropositivity | 2 | 2001 | 971 | 0.140 |
Why?
|
Enterovirus Infections | 5 | 1989 | 72 | 0.130 |
Why?
|
Coxsackievirus Infections | 5 | 1989 | 44 | 0.130 |
Why?
|
Vidarabine | 4 | 1991 | 345 | 0.130 |
Why?
|
Chickenpox | 3 | 1990 | 131 | 0.120 |
Why?
|
Amino Acid Substitution | 4 | 2011 | 1793 | 0.120 |
Why?
|
Cardiovirus Infections | 2 | 2005 | 19 | 0.120 |
Why?
|
Base Sequence | 10 | 2007 | 12798 | 0.120 |
Why?
|
Cytomegalovirus Retinitis | 3 | 2003 | 58 | 0.120 |
Why?
|
CD4 Lymphocyte Count | 9 | 2009 | 2560 | 0.120 |
Why?
|
Neomycin | 1 | 1993 | 88 | 0.110 |
Why?
|
Blood Pressure | 1 | 2009 | 8551 | 0.110 |
Why?
|
Virus Diseases | 4 | 1995 | 711 | 0.110 |
Why?
|
Skin Diseases, Infectious | 2 | 1990 | 74 | 0.110 |
Why?
|
Virus Integration | 2 | 2007 | 299 | 0.110 |
Why?
|
Cell Transformation, Viral | 6 | 1985 | 566 | 0.110 |
Why?
|
Viremia | 3 | 2009 | 736 | 0.110 |
Why?
|
Antibodies, Viral | 7 | 2003 | 3175 | 0.100 |
Why?
|
Pyrrolidinones | 2 | 2009 | 117 | 0.100 |
Why?
|
Cell Line | 18 | 2009 | 15993 | 0.100 |
Why?
|
Viral Hepatitis Vaccines | 3 | 1986 | 80 | 0.100 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 1992 | 112 | 0.100 |
Why?
|
Reverse Transcriptase Inhibitors | 4 | 1999 | 615 | 0.100 |
Why?
|
Chemotactic Factors | 1 | 1992 | 199 | 0.100 |
Why?
|
Bromodeoxyuridine | 4 | 1987 | 322 | 0.100 |
Why?
|
Antigens, CD34 | 2 | 2010 | 658 | 0.090 |
Why?
|
Inflammation | 1 | 2010 | 10629 | 0.090 |
Why?
|
Cells, Cultured | 13 | 2011 | 19232 | 0.090 |
Why?
|
DNA Replication | 6 | 2002 | 1399 | 0.090 |
Why?
|
Hematoporphyrins | 2 | 1980 | 23 | 0.090 |
Why?
|
AIDS-Related Complex | 3 | 1994 | 110 | 0.090 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 2 | 2002 | 222 | 0.090 |
Why?
|
Chemokines, CXC | 1 | 1992 | 422 | 0.090 |
Why?
|
Cytokines | 3 | 2009 | 7324 | 0.090 |
Why?
|
Cytarabine | 4 | 1986 | 692 | 0.090 |
Why?
|
Drug Interactions | 5 | 1996 | 1460 | 0.090 |
Why?
|
Diet, Atherogenic | 1 | 2009 | 96 | 0.090 |
Why?
|
Growth Substances | 1 | 1992 | 784 | 0.090 |
Why?
|
Microbial Sensitivity Tests | 7 | 2003 | 1870 | 0.090 |
Why?
|
Methylene Blue | 2 | 1980 | 155 | 0.080 |
Why?
|
RNA Probes | 3 | 1995 | 113 | 0.080 |
Why?
|
Gene Expression | 4 | 2005 | 7793 | 0.080 |
Why?
|
Light | 3 | 1980 | 1365 | 0.080 |
Why?
|
Indoles | 1 | 1997 | 1841 | 0.080 |
Why?
|
DNA Polymerase I | 1 | 1988 | 38 | 0.080 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3645 | 0.080 |
Why?
|
Electricity | 2 | 1980 | 182 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 1997 | 4422 | 0.080 |
Why?
|
Antigens, Viral | 6 | 1998 | 1035 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1997 | 2281 | 0.070 |
Why?
|
Hybridization, Genetic | 6 | 1973 | 109 | 0.070 |
Why?
|
Cyclic GMP | 2 | 1985 | 408 | 0.070 |
Why?
|
Leucine | 2 | 1999 | 559 | 0.070 |
Why?
|
Renin | 1 | 2009 | 642 | 0.070 |
Why?
|
Polyradiculopathy | 1 | 1986 | 23 | 0.070 |
Why?
|
Simian virus 40 | 6 | 1973 | 297 | 0.070 |
Why?
|
Lymphocytes | 6 | 1995 | 2615 | 0.070 |
Why?
|
Organic Chemicals | 1 | 2007 | 210 | 0.070 |
Why?
|
Genes | 3 | 1984 | 1893 | 0.070 |
Why?
|
Sulfamethoxazole | 1 | 1986 | 53 | 0.070 |
Why?
|
California | 1 | 2010 | 1402 | 0.070 |
Why?
|
Protein Biosynthesis | 4 | 1993 | 2123 | 0.070 |
Why?
|
Hepatitis B | 3 | 1986 | 693 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 1997 | 3794 | 0.070 |
Why?
|
Enterovirus B, Human | 4 | 1988 | 52 | 0.070 |
Why?
|
Trimethoprim | 1 | 1986 | 91 | 0.070 |
Why?
|
Phenotype | 3 | 2022 | 16361 | 0.070 |
Why?
|
Plasmids | 5 | 2000 | 2308 | 0.070 |
Why?
|
Angiotensin II | 1 | 2009 | 880 | 0.070 |
Why?
|
Vero Cells | 6 | 2011 | 485 | 0.070 |
Why?
|
HIV Integrase Inhibitors | 1 | 2007 | 142 | 0.070 |
Why?
|
Viruses | 1 | 1989 | 374 | 0.070 |
Why?
|
Adrenergic Agonists | 1 | 2005 | 58 | 0.060 |
Why?
|
Male | 53 | 2012 | 349776 | 0.060 |
Why?
|
Animals | 45 | 2011 | 168660 | 0.060 |
Why?
|
Tumor Cells, Cultured | 3 | 2002 | 6311 | 0.060 |
Why?
|
Immunization, Passive | 2 | 2003 | 623 | 0.060 |
Why?
|
Gene Expression Regulation, Viral | 2 | 2000 | 442 | 0.060 |
Why?
|
Double-Blind Method | 12 | 2009 | 12020 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2010 | 15142 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 1992 | 1678 | 0.060 |
Why?
|
Viral Load | 4 | 2003 | 3300 | 0.060 |
Why?
|
Epinephrine | 2 | 2005 | 792 | 0.060 |
Why?
|
RNA-Directed DNA Polymerase | 3 | 1995 | 248 | 0.060 |
Why?
|
Ataxia | 1 | 1986 | 304 | 0.060 |
Why?
|
Molecular Sequence Data | 5 | 2001 | 18107 | 0.060 |
Why?
|
Propranolol | 1 | 2005 | 502 | 0.060 |
Why?
|
Lamivudine | 2 | 2007 | 342 | 0.060 |
Why?
|
Pandemics | 1 | 2023 | 8385 | 0.060 |
Why?
|
Occupational Diseases | 3 | 1986 | 1466 | 0.060 |
Why?
|
Blood Vessels | 1 | 2009 | 1124 | 0.060 |
Why?
|
Adenoviridae | 6 | 1973 | 1100 | 0.050 |
Why?
|
Colombia | 1 | 2003 | 258 | 0.050 |
Why?
|
Cell Division | 4 | 1993 | 4568 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3503 | 0.050 |
Why?
|
Interferon-alpha | 1 | 2007 | 895 | 0.050 |
Why?
|
Transduction, Genetic | 1 | 2005 | 913 | 0.050 |
Why?
|
Proviruses | 2 | 2011 | 318 | 0.050 |
Why?
|
Antibodies, Heterophile | 1 | 1982 | 126 | 0.050 |
Why?
|
Genes, rev | 1 | 2001 | 13 | 0.050 |
Why?
|
Genes, tat | 1 | 2001 | 15 | 0.050 |
Why?
|
Infectious Mononucleosis | 1 | 1982 | 131 | 0.050 |
Why?
|
Cloning, Molecular | 5 | 1993 | 4320 | 0.050 |
Why?
|
Genes, nef | 1 | 2001 | 55 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3874 | 0.050 |
Why?
|
DNA Primase | 1 | 2002 | 109 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2011 | 2566 | 0.050 |
Why?
|
Genetic Complementation Test | 4 | 1988 | 561 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 3 | 1997 | 3772 | 0.050 |
Why?
|
Spinal Puncture | 1 | 2003 | 281 | 0.050 |
Why?
|
Aorta | 1 | 2009 | 2062 | 0.050 |
Why?
|
Recombination, Genetic | 5 | 1993 | 1586 | 0.050 |
Why?
|
Flow Cytometry | 4 | 2005 | 5973 | 0.050 |
Why?
|
Stomatitis, Herpetic | 2 | 1991 | 12 | 0.050 |
Why?
|
Female | 38 | 2012 | 380020 | 0.050 |
Why?
|
Adult | 36 | 2009 | 213889 | 0.050 |
Why?
|
Ultraviolet Rays | 4 | 1987 | 1060 | 0.050 |
Why?
|
Thymidine | 6 | 1987 | 310 | 0.050 |
Why?
|
Mice | 24 | 2011 | 81154 | 0.050 |
Why?
|
Blotting, Northern | 2 | 1992 | 1581 | 0.050 |
Why?
|
RNA, Small Interfering | 2 | 2007 | 3504 | 0.050 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 2000 | 222 | 0.050 |
Why?
|
Bone Marrow Transplantation | 1 | 1988 | 2764 | 0.040 |
Why?
|
Maternal-Fetal Exchange | 1 | 1982 | 456 | 0.040 |
Why?
|
Mice, Inbred BALB C | 6 | 2011 | 6380 | 0.040 |
Why?
|
Codon | 2 | 1999 | 611 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 5 | 1991 | 1374 | 0.040 |
Why?
|
Cell Cycle | 2 | 2007 | 2963 | 0.040 |
Why?
|
Topotecan | 2 | 1997 | 137 | 0.040 |
Why?
|
Perylene | 1 | 1999 | 18 | 0.040 |
Why?
|
Macromolecular Substances | 1 | 2002 | 1454 | 0.040 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2005 | 1240 | 0.040 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1991 | 1085 | 0.040 |
Why?
|
Pneumonia, Viral | 5 | 1991 | 3241 | 0.040 |
Why?
|
Endogenous Retroviruses | 1 | 2000 | 112 | 0.040 |
Why?
|
Mutant Proteins | 2 | 2011 | 500 | 0.040 |
Why?
|
Gene Silencing | 1 | 2005 | 1537 | 0.040 |
Why?
|
Mortality | 1 | 2010 | 2862 | 0.040 |
Why?
|
Arabinofuranosyluracil | 1 | 1998 | 10 | 0.040 |
Why?
|
Binding, Competitive | 1 | 2000 | 1157 | 0.040 |
Why?
|
RNA Interference | 1 | 2007 | 2890 | 0.040 |
Why?
|
Zinc Fingers | 1 | 2000 | 583 | 0.040 |
Why?
|
Hepatitis B Surface Antigens | 4 | 1986 | 304 | 0.040 |
Why?
|
Virion | 1 | 1980 | 433 | 0.040 |
Why?
|
Serum Amyloid A Protein | 1 | 1997 | 121 | 0.040 |
Why?
|
Cross Infection | 2 | 1984 | 1416 | 0.040 |
Why?
|
Receptors, Interleukin-2 | 2 | 1997 | 573 | 0.040 |
Why?
|
Interferon Type I | 4 | 1989 | 541 | 0.040 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2007 | 1861 | 0.040 |
Why?
|
Travel | 1 | 2003 | 788 | 0.040 |
Why?
|
Methionine | 1 | 1999 | 590 | 0.040 |
Why?
|
Hepatitis B Antibodies | 3 | 1986 | 158 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2007 | 2850 | 0.030 |
Why?
|
Membrane Fusion | 1 | 1998 | 276 | 0.030 |
Why?
|
Cocaine | 1 | 2002 | 1007 | 0.030 |
Why?
|
Giant Cells | 1 | 1996 | 187 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2007 | 2916 | 0.030 |
Why?
|
Disease Models, Animal | 6 | 2009 | 18027 | 0.030 |
Why?
|
Laboratories | 1 | 2000 | 462 | 0.030 |
Why?
|
HIV Envelope Protein gp41 | 1 | 1998 | 314 | 0.030 |
Why?
|
Virulence | 2 | 2011 | 1328 | 0.030 |
Why?
|
Drug Therapy, Combination | 4 | 2007 | 6487 | 0.030 |
Why?
|
Receptors, CCR5 | 1 | 1998 | 498 | 0.030 |
Why?
|
Fever | 1 | 2003 | 1616 | 0.030 |
Why?
|
Gene Expression Regulation | 3 | 1988 | 12066 | 0.030 |
Why?
|
Latex Fixation Tests | 1 | 1995 | 32 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2003 | 1656 | 0.030 |
Why?
|
Immediate-Early Proteins | 1 | 1998 | 453 | 0.030 |
Why?
|
Glycoproteins | 2 | 1982 | 2266 | 0.030 |
Why?
|
Mice, Inbred DBA | 5 | 1989 | 642 | 0.030 |
Why?
|
Cricetinae | 3 | 2000 | 2475 | 0.030 |
Why?
|
HeLa Cells | 2 | 2000 | 3130 | 0.030 |
Why?
|
Research | 1 | 2003 | 1999 | 0.030 |
Why?
|
Cell Survival | 3 | 1997 | 5881 | 0.030 |
Why?
|
Time Factors | 12 | 2007 | 40038 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2011 | 21824 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1999 | 2839 | 0.030 |
Why?
|
Molecular Probe Techniques | 1 | 1995 | 119 | 0.030 |
Why?
|
Zalcitabine | 1 | 1994 | 42 | 0.030 |
Why?
|
Lymphocyte Activation | 3 | 1991 | 5524 | 0.030 |
Why?
|
Neoplasm Proteins | 1 | 2007 | 3706 | 0.030 |
Why?
|
Recombinant Proteins | 6 | 1993 | 6620 | 0.030 |
Why?
|
Transcription Factors | 2 | 2007 | 12209 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4749 | 0.030 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 1998 | 570 | 0.030 |
Why?
|
Interleukin-1 | 1 | 1997 | 1263 | 0.030 |
Why?
|
Colitis | 2 | 1993 | 1170 | 0.030 |
Why?
|
DNA Primers | 1 | 1998 | 2891 | 0.030 |
Why?
|
HIV Envelope Protein gp120 | 1 | 1998 | 952 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2002 | 2969 | 0.030 |
Why?
|
Restriction Mapping | 2 | 1993 | 878 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2007 | 5021 | 0.030 |
Why?
|
Fibroblasts | 2 | 2003 | 4162 | 0.030 |
Why?
|
Genetic Vectors | 3 | 2005 | 3421 | 0.030 |
Why?
|
Receptors, CXCR4 | 1 | 1998 | 727 | 0.030 |
Why?
|
Models, Biological | 2 | 2009 | 9582 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1996 | 1723 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2003 | 19894 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2009 | 3445 | 0.030 |
Why?
|
Naphthoquinones | 1 | 1993 | 77 | 0.030 |
Why?
|
Blood Donors | 1 | 1995 | 355 | 0.030 |
Why?
|
Drug Administration Schedule | 3 | 2009 | 4931 | 0.030 |
Why?
|
Proteins | 2 | 2007 | 6098 | 0.030 |
Why?
|
Hepatitis B Vaccines | 4 | 1986 | 194 | 0.030 |
Why?
|
Middle Aged | 15 | 2009 | 213241 | 0.030 |
Why?
|
DNA, Recombinant | 1 | 1993 | 476 | 0.030 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1992 | 192 | 0.030 |
Why?
|
Selection, Genetic | 1 | 1997 | 914 | 0.030 |
Why?
|
Simian immunodeficiency virus | 1 | 1998 | 846 | 0.030 |
Why?
|
DNA-Binding Proteins | 3 | 2000 | 9648 | 0.030 |
Why?
|
RNA, Antisense | 1 | 1992 | 136 | 0.030 |
Why?
|
Exodeoxyribonucleases | 1 | 1993 | 180 | 0.030 |
Why?
|
Administration, Topical | 3 | 1984 | 689 | 0.030 |
Why?
|
Point Mutation | 1 | 1997 | 1623 | 0.030 |
Why?
|
Curcumin | 1 | 1993 | 96 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 1997 | 2029 | 0.030 |
Why?
|
Chemokine CXCL1 | 1 | 1992 | 101 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5854 | 0.030 |
Why?
|
Transfection | 1 | 2000 | 5892 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1997 | 1374 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2009 | 10940 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2011 | 4477 | 0.020 |
Why?
|
Genotype | 3 | 2003 | 12944 | 0.020 |
Why?
|
Clinical Trials as Topic | 8 | 1995 | 7908 | 0.020 |
Why?
|
Retinitis | 1 | 1991 | 35 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1996 | 685 | 0.020 |
Why?
|
Seizures | 1 | 2003 | 2850 | 0.020 |
Why?
|
Eye Infections, Viral | 1 | 1991 | 57 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1994 | 902 | 0.020 |
Why?
|
T-Phages | 1 | 1990 | 90 | 0.020 |
Why?
|
Kinetics | 4 | 1993 | 6476 | 0.020 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 1992 | 371 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1990 | 427 | 0.020 |
Why?
|
Photochemistry | 2 | 1980 | 237 | 0.020 |
Why?
|
Interferons | 2 | 1984 | 706 | 0.020 |
Why?
|
Substance Abuse, Intravenous | 1 | 1994 | 525 | 0.020 |
Why?
|
Clone Cells | 1 | 1993 | 1692 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2003 | 12954 | 0.020 |
Why?
|
Recurrence | 7 | 1998 | 8337 | 0.020 |
Why?
|
Alkynes | 1 | 2009 | 305 | 0.020 |
Why?
|
Immunization Schedule | 2 | 1987 | 221 | 0.020 |
Why?
|
Templates, Genetic | 1 | 1988 | 211 | 0.020 |
Why?
|
Cyclopropanes | 1 | 2009 | 415 | 0.020 |
Why?
|
Drug Evaluation | 2 | 1987 | 647 | 0.020 |
Why?
|
Benzoxazines | 1 | 2009 | 301 | 0.020 |
Why?
|
Rhinovirus | 1 | 1989 | 187 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 1996 | 1171 | 0.020 |
Why?
|
Interleukin-6 | 1 | 1997 | 3208 | 0.020 |
Why?
|
Stromal Cells | 1 | 1993 | 1356 | 0.020 |
Why?
|
Hypnosis | 1 | 1987 | 82 | 0.020 |
Why?
|
Heart | 4 | 2002 | 4460 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 1988 | 454 | 0.020 |
Why?
|
Thailand | 1 | 2007 | 299 | 0.020 |
Why?
|
Retroviridae | 1 | 1989 | 913 | 0.020 |
Why?
|
Polyethylene Glycols | 2 | 1982 | 1181 | 0.020 |
Why?
|
DNA Repair | 2 | 1987 | 2045 | 0.020 |
Why?
|
Haploidy | 1 | 1986 | 136 | 0.020 |
Why?
|
Cauda Equina | 1 | 1986 | 42 | 0.020 |
Why?
|
Latin America | 1 | 2007 | 379 | 0.020 |
Why?
|
Cyclosporins | 1 | 1986 | 220 | 0.020 |
Why?
|
Probability | 1 | 1992 | 2505 | 0.020 |
Why?
|
Hematocrit | 1 | 1987 | 636 | 0.020 |
Why?
|
Spinal Nerve Roots | 1 | 1986 | 121 | 0.020 |
Why?
|
Transplantation | 1 | 1987 | 217 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1988 | 1800 | 0.020 |
Why?
|
Infusions, Parenteral | 1 | 1986 | 419 | 0.020 |
Why?
|
Diarrhea | 1 | 1993 | 1348 | 0.020 |
Why?
|
South Africa | 1 | 2011 | 1731 | 0.020 |
Why?
|
Hepatitis B virus | 2 | 1984 | 513 | 0.020 |
Why?
|
Influenza A virus | 1 | 1989 | 457 | 0.020 |
Why?
|
Deltaretrovirus | 1 | 1985 | 170 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 1997 | 3778 | 0.020 |
Why?
|
DNA Viruses | 1 | 1985 | 36 | 0.020 |
Why?
|
Personnel, Hospital | 2 | 1984 | 283 | 0.020 |
Why?
|
Molecular Weight | 4 | 1990 | 2253 | 0.020 |
Why?
|
Deoxyguanosine | 1 | 1985 | 84 | 0.020 |
Why?
|
Encephalitis | 1 | 1989 | 424 | 0.020 |
Why?
|
Gene Deletion | 1 | 1993 | 2749 | 0.020 |
Why?
|
Immunity | 1 | 1991 | 1013 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 1999 | 1422 | 0.020 |
Why?
|
Kidney | 8 | 1984 | 7185 | 0.020 |
Why?
|
Papillomavirus Vaccines | 1 | 2011 | 491 | 0.020 |
Why?
|
HLA-DR Antigens | 1 | 1986 | 645 | 0.020 |
Why?
|
Pneumonia | 1 | 1996 | 2133 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1993 | 4737 | 0.020 |
Why?
|
Centrifugation, Density Gradient | 4 | 1973 | 313 | 0.020 |
Why?
|
Corynebacterium Infections | 1 | 1984 | 27 | 0.020 |
Why?
|
Complement System Proteins | 2 | 1986 | 796 | 0.020 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1986 | 249 | 0.020 |
Why?
|
Epitopes | 1 | 2011 | 2570 | 0.020 |
Why?
|
Sacrum | 1 | 1986 | 288 | 0.020 |
Why?
|
Australia | 1 | 2007 | 1167 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2001 | 13809 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2011 | 4386 | 0.010 |
Why?
|
Actins | 1 | 1992 | 2121 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 4 | 1990 | 2503 | 0.010 |
Why?
|
Cohort Studies | 3 | 2003 | 40545 | 0.010 |
Why?
|
Heart Valve Prosthesis | 2 | 1984 | 1489 | 0.010 |
Why?
|
Amnion | 1 | 2005 | 209 | 0.010 |
Why?
|
DNA Restriction Enzymes | 2 | 1980 | 570 | 0.010 |
Why?
|
United States | 3 | 2011 | 69859 | 0.010 |
Why?
|
Bereavement | 1 | 1987 | 278 | 0.010 |
Why?
|
Administration, Oral | 3 | 1999 | 3912 | 0.010 |
Why?
|
Hematopoiesis | 1 | 1993 | 2073 | 0.010 |
Why?
|
Genetic Variation | 2 | 1996 | 6535 | 0.010 |
Why?
|
Tritium | 5 | 1984 | 745 | 0.010 |
Why?
|
Mice, Inbred C3H | 3 | 1989 | 964 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1988 | 1676 | 0.010 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2005 | 222 | 0.010 |
Why?
|
Cesium | 3 | 1971 | 38 | 0.010 |
Why?
|
Goats | 1 | 2003 | 171 | 0.010 |
Why?
|
Nucleic Acid Denaturation | 3 | 1973 | 111 | 0.010 |
Why?
|
Lentivirus | 1 | 2005 | 503 | 0.010 |
Why?
|
Immune Sera | 1 | 2003 | 641 | 0.010 |
Why?
|
Keratins | 1 | 1984 | 515 | 0.010 |
Why?
|
Adenine | 1 | 2007 | 935 | 0.010 |
Why?
|
Canada | 1 | 2007 | 2064 | 0.010 |
Why?
|
Cytopathogenic Effect, Viral | 2 | 1980 | 156 | 0.010 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1986 | 1475 | 0.010 |
Why?
|
Myocardium | 5 | 2002 | 4775 | 0.010 |
Why?
|
Radiation Injuries | 1 | 1989 | 1180 | 0.010 |
Why?
|
Echocardiography | 1 | 1994 | 5096 | 0.010 |
Why?
|
Horses | 1 | 1982 | 304 | 0.010 |
Why?
|
Catheters, Indwelling | 1 | 1984 | 427 | 0.010 |
Why?
|
Survival | 1 | 2002 | 163 | 0.010 |
Why?
|
Penicillin G | 1 | 1981 | 42 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2002 | 424 | 0.010 |
Why?
|
Placebos | 2 | 1984 | 1674 | 0.010 |
Why?
|
Transcription, Genetic | 3 | 1993 | 7719 | 0.010 |
Why?
|
Deoxycytidine | 1 | 1985 | 826 | 0.010 |
Why?
|
Antibody Specificity | 2 | 1998 | 1095 | 0.010 |
Why?
|
Prognosis | 3 | 1996 | 29052 | 0.010 |
Why?
|
Interferon-gamma | 1 | 1989 | 3205 | 0.010 |
Why?
|
Cardiomyopathy, Dilated | 1 | 1987 | 851 | 0.010 |
Why?
|
HLA Antigens | 1 | 1986 | 1382 | 0.010 |
Why?
|
Epidermis | 1 | 1984 | 529 | 0.010 |
Why?
|
Drug Combinations | 1 | 1986 | 1958 | 0.010 |
Why?
|
Agammaglobulinemia | 1 | 1982 | 167 | 0.010 |
Why?
|
Mice, SCID | 1 | 2005 | 2718 | 0.010 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2001 | 224 | 0.010 |
Why?
|
Arabinonucleotides | 1 | 1979 | 5 | 0.010 |
Why?
|
Adrenalectomy | 1 | 2002 | 342 | 0.010 |
Why?
|
Vidarabine Phosphate | 1 | 1979 | 11 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1984 | 636 | 0.010 |
Why?
|
Chlorides | 3 | 1971 | 667 | 0.010 |
Why?
|
Sheep | 1 | 1982 | 1437 | 0.010 |
Why?
|
Aged | 8 | 2007 | 163178 | 0.010 |
Why?
|
Acute Disease | 2 | 2005 | 7150 | 0.010 |
Why?
|
Analysis of Variance | 2 | 2005 | 6356 | 0.010 |
Why?
|
Dermatitis, Phototoxic | 1 | 1999 | 15 | 0.010 |
Why?
|
Norepinephrine | 1 | 2002 | 909 | 0.010 |
Why?
|
Anthracenes | 1 | 1999 | 86 | 0.010 |
Why?
|
Binding Sites | 2 | 1993 | 6111 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2009 | 12354 | 0.010 |
Why?
|
Leukocytes | 1 | 1987 | 2044 | 0.010 |
Why?
|
Gene Amplification | 1 | 2003 | 1063 | 0.010 |
Why?
|
Nucleotides | 1 | 1981 | 463 | 0.010 |
Why?
|
Molecular Biology | 3 | 1971 | 595 | 0.010 |
Why?
|
Haplorhini | 4 | 1973 | 548 | 0.010 |
Why?
|
Psychotherapy | 1 | 1987 | 1640 | 0.010 |
Why?
|
Superoxides | 1 | 1979 | 387 | 0.010 |
Why?
|
DNA, Single-Stranded | 1 | 1980 | 354 | 0.010 |
Why?
|
Rabbits | 2 | 1987 | 4894 | 0.010 |
Why?
|
Uterus | 1 | 1982 | 711 | 0.010 |
Why?
|
Random Allocation | 3 | 1989 | 2429 | 0.010 |
Why?
|
Leukocyte Count | 2 | 1992 | 1588 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5179 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 1988 | 2750 | 0.010 |
Why?
|
Temperature | 1 | 1984 | 2202 | 0.010 |
Why?
|
Herpesvirus 4, Human | 1 | 1982 | 1041 | 0.010 |
Why?
|
Disease Progression | 3 | 2002 | 13273 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 1986 | 1848 | 0.010 |
Why?
|
Antibodies | 2 | 1998 | 2459 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 2005 | 1542 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 2 | 1998 | 1837 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2005 | 1620 | 0.010 |
Why?
|
Dimerization | 1 | 1998 | 894 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2003 | 35409 | 0.010 |
Why?
|
Treatment Outcome | 5 | 2007 | 63042 | 0.010 |
Why?
|
DNA | 4 | 1991 | 7295 | 0.010 |
Why?
|
Postoperative Complications | 2 | 1988 | 15281 | 0.010 |
Why?
|
Chronic Disease | 2 | 2005 | 9139 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2000 | 1851 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 2005 | 2267 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 1984 | 1400 | 0.010 |
Why?
|
Centrifugation, Zonal | 2 | 1971 | 14 | 0.010 |
Why?
|
Fetus | 1 | 1982 | 1880 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 1988 | 4665 | 0.010 |
Why?
|
Genetics, Microbial | 2 | 1971 | 60 | 0.010 |
Why?
|
Phylogeny | 1 | 2001 | 2796 | 0.010 |
Why?
|
Genes, pol | 1 | 1993 | 51 | 0.010 |
Why?
|
Sucrose | 2 | 1971 | 164 | 0.010 |
Why?
|
Cytosine | 2 | 1973 | 216 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 1999 | 2883 | 0.010 |
Why?
|
Heart Valve Diseases | 1 | 1981 | 1073 | 0.010 |
Why?
|
Placenta | 1 | 1982 | 1699 | 0.010 |
Why?
|
Erythrocytes | 1 | 1982 | 2455 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 1988 | 4251 | 0.010 |
Why?
|
Liver Diseases | 1 | 1981 | 1253 | 0.010 |
Why?
|
Stress, Psychological | 1 | 1987 | 4245 | 0.010 |
Why?
|
Organ Size | 2 | 1988 | 2241 | 0.010 |
Why?
|
Spleen | 2 | 1988 | 2359 | 0.010 |
Why?
|
Concanavalin A | 1 | 1991 | 191 | 0.010 |
Why?
|
Adolescent | 4 | 2007 | 85729 | 0.010 |
Why?
|
Chymotrypsin | 1 | 1971 | 149 | 0.010 |
Why?
|
Phosphorus Isotopes | 1 | 1970 | 126 | 0.010 |
Why?
|
HIV Envelope Protein gp160 | 1 | 1991 | 99 | 0.010 |
Why?
|
Patient Compliance | 2 | 1992 | 2683 | 0.010 |
Why?
|
Microscopy, Electron | 2 | 1973 | 2646 | 0.010 |
Why?
|
Colony-Forming Units Assay | 1 | 1991 | 355 | 0.010 |
Why?
|
Hepatitis A | 1 | 1971 | 133 | 0.010 |
Why?
|
Lung Diseases | 1 | 1981 | 1887 | 0.010 |
Why?
|
Capsules | 1 | 1991 | 196 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1988 | 10179 | 0.010 |
Why?
|
Open Reading Frames | 1 | 1993 | 811 | 0.010 |
Why?
|
Gene Products, env | 1 | 1991 | 263 | 0.010 |
Why?
|
DNA Probes | 1 | 1991 | 560 | 0.010 |
Why?
|
Mice, Inbred Strains | 2 | 1983 | 1826 | 0.010 |
Why?
|
Skin | 1 | 2003 | 4372 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2005 | 10477 | 0.010 |
Why?
|
Platinum | 1 | 1971 | 231 | 0.010 |
Why?
|
Mutagenesis | 1 | 1993 | 1263 | 0.010 |
Why?
|
Deoxyribonuclease BamHI | 1 | 1988 | 17 | 0.010 |
Why?
|
Deoxyribonuclease EcoRI | 1 | 1988 | 31 | 0.010 |
Why?
|
Risk | 2 | 1996 | 9677 | 0.010 |
Why?
|
Biopsy | 2 | 1993 | 6750 | 0.010 |
Why?
|
Sequence Deletion | 1 | 1993 | 1524 | 0.010 |
Why?
|
Virus Cultivation | 3 | 1973 | 92 | 0.010 |
Why?
|
Hot Temperature | 2 | 1973 | 1351 | 0.010 |
Why?
|
Genetic Markers | 1 | 1995 | 2634 | 0.010 |
Why?
|
Neutropenia | 1 | 1994 | 895 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2003 | 14714 | 0.000 |
Why?
|
Oxygen | 1 | 1980 | 4189 | 0.000 |
Why?
|
Autoimmune Diseases | 1 | 1980 | 2134 | 0.000 |
Why?
|
Drug Resistance | 1 | 1993 | 1606 | 0.000 |
Why?
|
Endomyocardial Fibrosis | 1 | 1987 | 41 | 0.000 |
Why?
|
Phytohemagglutinins | 1 | 1987 | 170 | 0.000 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1989 | 906 | 0.000 |
Why?
|
Arthritis, Infectious | 1 | 1971 | 367 | 0.000 |
Why?
|
Carbon | 1 | 1971 | 686 | 0.000 |
Why?
|
Lectins | 1 | 1989 | 513 | 0.000 |
Why?
|
Follow-Up Studies | 3 | 1999 | 39001 | 0.000 |
Why?
|
Sex Factors | 1 | 1981 | 10394 | 0.000 |
Why?
|
Carbon Isotopes | 3 | 1973 | 468 | 0.000 |
Why?
|
Maus Elberfeld virus | 1 | 1986 | 5 | 0.000 |
Why?
|
Protein Precursors | 1 | 1991 | 1154 | 0.000 |
Why?
|
Immunity, Maternally-Acquired | 1 | 1987 | 118 | 0.000 |
Why?
|
Liver | 1 | 1982 | 7479 | 0.000 |
Why?
|
Sarcoma, Kaposi | 1 | 1989 | 370 | 0.000 |
Why?
|
Vaccines, Attenuated | 1 | 1987 | 342 | 0.000 |
Why?
|
Lymphokines | 1 | 1989 | 948 | 0.000 |
Why?
|
Mouth Mucosa | 1 | 1989 | 432 | 0.000 |
Why?
|
Infant | 1 | 1988 | 35122 | 0.000 |
Why?
|
Chemical Precipitation | 1 | 1985 | 179 | 0.000 |
Why?
|
Myosins | 1 | 1987 | 409 | 0.000 |
Why?
|
Cell Communication | 1 | 1993 | 1621 | 0.000 |
Why?
|
Antigens | 1 | 1971 | 1466 | 0.000 |
Why?
|
Hepatitis B Core Antigens | 1 | 1985 | 92 | 0.000 |
Why?
|
Immunoblotting | 1 | 1988 | 1683 | 0.000 |
Why?
|
Colonoscopy | 1 | 1993 | 1367 | 0.000 |
Why?
|
Mice, Inbred ICR | 1 | 1985 | 352 | 0.000 |
Why?
|
Phosphorus Radioisotopes | 1 | 1984 | 104 | 0.000 |
Why?
|
Drug Contamination | 1 | 1985 | 147 | 0.000 |
Why?
|
Herpesvirus 3, Human | 1 | 1985 | 204 | 0.000 |
Why?
|
Age Factors | 1 | 1981 | 18355 | 0.000 |
Why?
|
Infant, Newborn | 2 | 2000 | 25609 | 0.000 |
Why?
|
Atrophy | 1 | 1988 | 1577 | 0.000 |
Why?
|
Antigens, Bacterial | 1 | 1989 | 1172 | 0.000 |
Why?
|
Immunization, Secondary | 1 | 1985 | 340 | 0.000 |
Why?
|
Rodent Diseases | 1 | 1983 | 57 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1986 | 20121 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1989 | 2369 | 0.000 |
Why?
|
Antibodies, Monoclonal | 2 | 1990 | 9272 | 0.000 |
Why?
|
Survival Analysis | 1 | 1995 | 10251 | 0.000 |
Why?
|
Isoenzymes | 1 | 1987 | 1728 | 0.000 |
Why?
|
Boston | 2 | 1985 | 9310 | 0.000 |
Why?
|
Necrosis | 1 | 1986 | 1642 | 0.000 |
Why?
|
Purine Nucleotides | 1 | 1981 | 28 | 0.000 |
Why?
|
Culture Techniques | 2 | 1973 | 553 | 0.000 |
Why?
|
Mesocricetus | 1 | 1981 | 252 | 0.000 |
Why?
|
Escherichia coli | 1 | 1993 | 4216 | 0.000 |
Why?
|
Virus Activation | 1 | 1983 | 319 | 0.000 |
Why?
|
Bone Marrow | 1 | 1991 | 2951 | 0.000 |
Why?
|
Pregnancy | 1 | 1982 | 29140 | 0.000 |
Why?
|
Ointments | 1 | 1979 | 59 | 0.000 |
Why?
|
Autoantibodies | 1 | 1987 | 2037 | 0.000 |
Why?
|
Immunologic Memory | 1 | 1985 | 1347 | 0.000 |
Why?
|
Convalescence | 1 | 1978 | 105 | 0.000 |
Why?
|
Survival Rate | 1 | 1992 | 12786 | 0.000 |
Why?
|
Risk Factors | 2 | 1995 | 72252 | 0.000 |
Why?
|
Cisplatin | 1 | 1984 | 1662 | 0.000 |
Why?
|
Embryo, Mammalian | 1 | 1984 | 1702 | 0.000 |
Why?
|
Monocytes | 1 | 1987 | 2593 | 0.000 |
Why?
|
Calcinosis | 1 | 1986 | 1495 | 0.000 |
Why?
|
Quality of Life | 1 | 1998 | 12788 | 0.000 |
Why?
|
Neutralization Tests | 1 | 1978 | 757 | 0.000 |
Why?
|
Phosphorylation | 1 | 1987 | 8436 | 0.000 |
Why?
|
Body Weight | 1 | 1986 | 4670 | 0.000 |
Why?
|
Lung | 2 | 1984 | 9858 | 0.000 |
Why?
|
Child | 1 | 1982 | 77637 | 0.000 |
Why?
|
Immune Tolerance | 1 | 1982 | 2258 | 0.000 |
Why?
|
Vaccination | 1 | 1984 | 3275 | 0.000 |
Why?
|
Hepatitis B Antigens | 1 | 1971 | 40 | 0.000 |
Why?
|
Histocompatibility Antigens | 1 | 1973 | 471 | 0.000 |
Why?
|
Genetic Code | 1 | 1971 | 154 | 0.000 |
Why?
|
Neoplasms | 1 | 1980 | 21675 | 0.000 |
Why?
|
Uridine | 1 | 1971 | 146 | 0.000 |
Why?
|
Hematuria | 1 | 1971 | 235 | 0.000 |
Why?
|
Erythema | 1 | 1971 | 257 | 0.000 |
Why?
|
Aspartate Aminotransferases | 1 | 1971 | 418 | 0.000 |
Why?
|
Liver Function Tests | 1 | 1971 | 529 | 0.000 |
Why?
|
Antigen-Antibody Complex | 1 | 1971 | 517 | 0.000 |
Why?
|
Synovial Fluid | 1 | 1971 | 394 | 0.000 |
Why?
|
Pain | 1 | 1984 | 4987 | 0.000 |
Why?
|
Mass Screening | 1 | 1984 | 5251 | 0.000 |
Why?
|
Retrospective Studies | 1 | 1995 | 77410 | 0.000 |
Why?
|
Aging | 1 | 1984 | 8655 | 0.000 |
Why?
|
Prospective Studies | 1 | 1989 | 53250 | 0.000 |
Why?
|
RNA | 1 | 1971 | 2748 | 0.000 |
Why?
|
Brain | 1 | 1987 | 26345 | 0.000 |
Why?
|